Esmaeili Behnaz, Ghadami Mohsen, Fazlollahi Mohammad Reza, Niroomanesh Shirin, Atarod Lida, Chavoshzadeh Zahra, Moradi Zeinab, Alizadeh Zahra, Pourpak Zahra
Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Iran J Allergy Asthma Immunol. 2014 Feb;13(1):61-5.
Leukocyte adhesion deficiency type-1(LAD-1) is one of the immunodeficiency autosomal recessive diseases that results from mutation in integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) ITGB2 gene. The aim of this study was to investigate molecular prenatal diagnosis of LAD-1. Four pregnant women with five fetuses (one pregnancy was twin) with clinical and laboratory diagnosis of LAD-1 in their previous children were studied. The chorionic villus sampling (CVS) was obtained when mothers were in 10-12th weeks of gestation. Mutation analysis of ITGB2 gene for affected children revealed 3 misssense mutations (c.382G>A, a novel mutation, c.2146G>C, and c.715G>A) and one splice site novel mutation (c.1877+2G>A). All of Parents were heterozygous for these mutations. Consideration of affected gene regions for five CVS samples showed two homozygotes and one heterozygote for mutant allele and two homozygotes for normal allele. Interestingly, one of the twin fetuses was affected and another was normal. Briefly, two cases of CVS samples were affected and three cases of remained CVS samples were unaffected.This is the first report of prenatal diagnosis of LAD-1 from Iran with two new mutations that can be used for genetic and prenatal diagnosis for all patients suspected to LAD1 and can be helpful to prevent the birth of affected children with LAD-1. This abstract presented in the second international congress of Immunology, Asthma and Allergy, Tehran, Iran 2013.
1型白细胞黏附缺陷症(LAD - 1)是一种常染色体隐性免疫缺陷疾病,由整合素β2(补体成分3受体3和4亚基)ITGB2基因突变引起。本研究旨在探讨LAD - 1的分子产前诊断。研究了4名孕妇及其5名胎儿(其中1例为双胎妊娠),这些孕妇之前的孩子经临床和实验室诊断患有LAD - 1。当母亲妊娠10 - 12周时采集绒毛膜绒毛取样(CVS)。对患病儿童的ITGB2基因进行突变分析,发现了3个错义突变(c.382G>A,一个新突变;c.2146G>C;c.715G>A)和一个剪接位点新突变(c.1877 + 2G>A)。所有父母均为这些突变的杂合子。对5份CVS样本的受累基因区域分析显示,有2个纯合子和1个杂合子携带突变等位基因,2个纯合子携带正常等位基因。有趣的是,双胎胎儿中的一个患病,另一个正常。简而言之,2份CVS样本受累,其余3份CVS样本未受累。这是来自伊朗的关于LAD - 1产前诊断的首次报告,发现了两个新突变;这些突变可用于所有疑似LAD1患者的基因诊断和产前诊断,有助于预防LAD - 1患病儿童的出生。本摘要发表于2013年在伊朗德黑兰举行的第二届国际免疫学、哮喘与过敏大会。